We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Complement Attacks Brain Cells After Mild Injury

By Biotechdaily staff writers
Posted on 07 Nov 2002
A study has shown that mild injury to the brain such as that caused by brief seizures, minimal head trauma or stroke, or transient anoxia increases the susceptibility of neurons to attack and destruction by complement, which can lead to neurodegeneration and diseases such as Alzheimer's. More...
This information was published in the October 24, 2002, issue of Neuron.

Investigators from Duke University Medical Center (Durham, NC, USA) exposed cultures of neurons and astrocytes to modest levels of glutamate, as might be generated by a mild insult to the brain. The cultures were then exposed to activated complement proteins, which selectively killed the neurons. The damage was found to be caused by the membrane attack pathway of complement. Glutamate treatment sensitized neurons, but not astrocytes, to attack by complement.

The complement immune system pathway consists of an "early activation” pathway that can be protective in Alzheimer's disease, and a "terminal” pathway, in which the proteins combine to create a "membrane attack complex.” It is the terminal pathway and the membrane attack complex that damage neurons sensitized to complement attack by mild brain insult.

"Basically, we have discovered how an insult like transient ischemic attacks, minimal drop in blood pressure, or a minimal blow to the head could facilitate the transition from the early activation pathway to the terminal membrane attack pathway, and transform a protective effect into a damaging effect on the brain,” explained senior author Dr. James O. McNamara, professor and chairman of Duke's department of neurobiology.





Related Links:
Duke Univ

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.